NOS2 and neoplasm: They loaded the immunotherapeutic drug cyclic dinucleotide (CDN) into inducible nitric oxide synthase (iNOS)-inhibited L-nil-MDP hydrogel, which effectively prolonged the median survival of tumor-bearing mice.